221 related articles for article (PubMed ID: 14980067)
1. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
Yu Z; Eaton JW; Persson HL
Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
[TBL] [Abstract][Full Text] [Related]
2. Prevention of oxidant-induced cell death by lysosomotropic iron chelators.
Persson HL; Yu Z; Tirosh O; Eaton JW; Brunk UT
Free Radic Biol Med; 2003 May; 34(10):1295-305. PubMed ID: 12726917
[TBL] [Abstract][Full Text] [Related]
3. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
4. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
Kurz T; Gustafsson B; Brunk UT
FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
[TBL] [Abstract][Full Text] [Related]
5. Intralysosomal iron: a major determinant of oxidant-induced cell death.
Yu Z; Persson HL; Eaton JW; Brunk UT
Free Radic Biol Med; 2003 May; 34(10):1243-52. PubMed ID: 12726912
[TBL] [Abstract][Full Text] [Related]
6. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.
Murley JS; Kataoka Y; Cao D; Li JJ; Oberley LW; Grdina DJ
Radiat Res; 2004 Nov; 162(5):536-46. PubMed ID: 15624308
[TBL] [Abstract][Full Text] [Related]
7. Selective exclusion by the polyamine transporter as a mechanism for differential radioprotection of amifostine derivatives.
Quiñones HI; List AF; Gerner EW
Clin Cancer Res; 2002 May; 8(5):1295-300. PubMed ID: 12006551
[TBL] [Abstract][Full Text] [Related]
8. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection.
Purdie JW; Inhaber ER; Schneider H; Labelle JL
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 May; 43(5):517-27. PubMed ID: 6303973
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive mechanisms of amifostine.
Ryan SV; Carrithers SL; Parkinson SJ; Skurk C; Nuss C; Pooler PM; Owen CS; Lefer AM; Waldman SA
J Clin Pharmacol; 1996 Apr; 36(4):365-73. PubMed ID: 8728352
[TBL] [Abstract][Full Text] [Related]
10. Protection from cellular oxidative injury and calcium intrusion by N-(2-mercaptoethyl)-1,3-propanediamine, WR 1065.
Polla BS; Donati Y; Kondo M; Tochon-Danguy HJ; Bonjour JP
Biochem Pharmacol; 1990 Oct; 40(7):1469-75. PubMed ID: 2171529
[TBL] [Abstract][Full Text] [Related]
11. WR-2721, its derivatives and their radioprotective effects on mammalian cells in culture.
Mori T; Watanabe M; Horikawa M; Nikaido P; Kimura H; Aoyama T; Sugahara T
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jul; 44(1):41-53. PubMed ID: 6305861
[TBL] [Abstract][Full Text] [Related]
12. Cystine depletion by WR-1065 in cystinotic cells. Mechanism of action.
Butler JD; Gahl WA; Tietze F
Biochem Pharmacol; 1985 Jun; 34(12):2179-85. PubMed ID: 2988568
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.
Smoluk GD; Fahey RC; Calabro-Jones PM; Aguilera JA; Ward JF
Cancer Res; 1988 Jul; 48(13):3641-7. PubMed ID: 2837320
[TBL] [Abstract][Full Text] [Related]
14. Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
Kataoka Y; Murley JS; Khodarev NN; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):180-9. PubMed ID: 12007958
[TBL] [Abstract][Full Text] [Related]
15. Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells.
Dziegielewski J; Goetz W; Murley JS; Grdina DJ; Morgan WF; Baulch JE
Radiat Res; 2010 Feb; 173(2):175-83. PubMed ID: 20095849
[TBL] [Abstract][Full Text] [Related]
16. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage.
Kurz T; Leake A; Von Zglinicki T; Brunk UT
Biochem J; 2004 Mar; 378(Pt 3):1039-45. PubMed ID: 14670081
[TBL] [Abstract][Full Text] [Related]
17. The effect of the radioprotector WR-2721 and WR-1065 on mitochondrial lipid peroxidation.
Tretter L; Rónai E; Szabados G; Hermann R; Andó A; Horváth I
Int J Radiat Biol; 1990 Mar; 57(3):467-78. PubMed ID: 1968940
[TBL] [Abstract][Full Text] [Related]
18. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
19. Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis.
Persson HL; Svensson AI; Brunk UT
Redox Rep; 2001; 6(5):327-34. PubMed ID: 11778851
[TBL] [Abstract][Full Text] [Related]
20. Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro.
Fulda S; Oster W; Berthold F
Anticancer Drugs; 1997 Jan; 8(1):34-41. PubMed ID: 9147609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
